This page shows the latest Lemtrada news and features for those working in and with pharma, biotech and healthcare.
For 2019 as a whole it topped 2.1bn in sales. Sanofi already has an established MS franchise with oral therapy Aubagio (teriflunomide) and Lemtrada (alemtuzumab), but that declined 3% to
Safety reviews of Lemtrada and Xeljanz. In addition to approving a number of new drugs, the CHMP also restricted the use of two medicines. ... This includes Sanofi Genzyme’s multiple sclerosis medicine Lemtrada(alemtuzumab), which now has restricted
It also pledged to take 'diligent effort' to get Lemtrada through development and onto the market quickly. ... It also claimed the company didn’t make the effort required for Lemtrada to reach its sales targets.
the disease if they have failed to respond to first-line treatment with Sanofi's Lemtrada (alemtuzumab) or have rapidly evolving severe MS.
The London-based agency picked up The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme
The London-based agency picked The Cello Health Award for Launch Excellence for work on behalf of Genzyme and its multiple sclerosis treatment Lemtrada. ... Lucid also picked up the Cello Health Award for Launch Excellence Award for supporting Genzyme
More from news
Approximately 9 fully matching, plus 20 partially matching documents found.
such as Aubagio (teriflunomide) and Lemtrada (alemtuzumab).
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Between May 2019 and May 2020, there was a reduction in several key treatments: Lemtrada, Tysabri and Gilenya. ... Lemtrada is a monoclonal antibody (MAB) given by infusion. Tysabri, or natalizumab, is also an infusion injection.
More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.
Our goal is to identify and embed transformational patient insights as a fundamental part of the drug development process. As...